Helping an Oral Diabetes Drug Go the Extra Mile (2 of 4) (IMAGE)

American Association for the Advancement of Science (AAAS)

Helping an Oral Diabetes Drug Go the Extra Mile (2 of 4)

Caption

SEMA/SNAC passing through epithelial cells to blood vessels where it can be absorbed and work to lower blood glucose and body weight. This material relates to a paper that appeared in the Nov. 14, 2018, issue of Science Translational Medicine, published by AAAS. The paper, by S.T. Buckley at ovo Nordisk A/S in Måløv, Denmark; and colleagues was titled, " Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist."

Credit

Stephen T Buckley

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.